Sharp Therapeutics Corp. (SHRX)
TSX Venture Exchange · Canada · prices in CAD · close of 15 Oct 2026
Key indicators
| Last close | CAD 1.370 |
|---|---|
| 52-week range | 0.910 – 5.000 |
| Return, 1 month / 3 months | +0.0% / +50.5% |
| Return, 1 year / 3 years | +37.0% / – |
| Trend | Below its 200-day average |
| RSI (14) | 96 |
| Volatility (1 year) | 141.8% |
| Worst drawdown (1 year) | -81.8% |
| Average daily value traded | 0.00M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Sharp Therapeutics Corp. (SHRX) trades on the TSX Venture Exchange in Canada. It last closed at CAD 1.370 on 15 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 1,204 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.0% and over the last three months it rose 50.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 22 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.2% | ||
| From 52-week high | -72.6% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 50.5% | ||
| 6-month return | -36.3% | ||
| 12-month return, skipping the last month | 37.0% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 141.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -81.8% | ||
| Liquidity | 11 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CAD | ||
| Zero-volume days | 96.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +50.5% |
| 6 months | −36.3% |
| 1 year | +37.0% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.158 / 1.717 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.005 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.